Objective: To examine the association of contraceptive use in the interpregnancy interval with subsequent child health outcomes in low-and middle-income countries.
INTRODUCTION
A handful of dedicated authors have persisted in promoting the importance of family planning over the past 20 years [1] [2] [3] [4] [5] [6] . However, a recent edition of the Lancet that addresses the health benefits of contraception [4, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] brings new energy to a field that had remained in the background while the fight against human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) dominated the field on this vital issue central to child and maternal health. Proponents of family planning have worked to increase the prevalence contraception, particularly in high fertility countries. In the past 20 years, the driving force behind this policy to increase contraceptive prevalence has been to address unmet need [4] .
The obvious benefit of contraceptive access and use is to aid women and couples in achieving their desired family size. However, contraceptive use is also associated with lower completed fertility [17, 18] , which has many health and economic benefits at both the children of women with lower fertility rates enjoy *Address corresponding to this author at the Harvard Centre for Population and Development Studies, 9 Bow St, Cambridge, MA 02138, USA; Tel: 617-372-735; Fax: 617-495-5418; E-mail: jfinlay@hsph.harvard.edu household [6, 19] and aggregate levels [3, 20] . The greater health compared to those in large families [21] [22] [23] . The economic benefits of lower fertility lead to encouragement of female participation in the labour force, savings, and education attainment, which combine to promote economic growth [3, [23] [24] [25] [26] [27] .
The side effects of the hormonal contraceptive pill have been well studied, as the pill is a central method of contraception in Western countries. In fact, many positive side effects have been documented [28] [29] [30] . However, the health benefits of contraception, particularly regarding the situation in developing countries, focus on maternal mortality reduction [7, 8, 22, [31] [32] [33] , notably by providing a means to avoid unsafe abortions [34] and assist women in achieving adequate spacing between births [5, [35] [36] [37] [38] [39] [40] [41] .
Contraceptive use can have positive effects on child health. Typically, these effects are thought of in the context of extending spacing between births, allowing the mother time to recover and restore nutritional balance. However, contraceptive use may lead to positive child health outcomes through other channels, over and above the effect it has on extending birth intervals. Contraceptive use may be indicative of contraceptive access and, more broadly, access to primary healthcare. Additionally, women may obtain contraception at a facility that also offers other maternal and child health facilities, provisions, and information. Thus, by attending a health care facility for the purpose of contraception, the mother-to-be is also indirectly gathering information on child health and gaining knowledge of the availability of programs to support her future child's health. Thus, these visits may also improve a woman's knowledge of her own health during a future pregnancy and the health of her future child. This argument works well for modern methods of contraception, but women also practice traditional methods of contraception, which may also have beneficial effects on child health. In this case, it may be that women who want to practice traditional methods of contraception discuss these methods with their female relatives and friends. As these women discuss contraception, they may also discuss general maternal and child health issues. Practicing any form of contraception, modern or traditional, may promote knowledge or at least mindfulness of the broader issues of maternal and child health, leading to significant improvements in child health outcomes.
A woman's contraceptive history, or lack thereof, rarely follows a "perfect" pattern. The data reveal that women seldom exist who space their children by two or more years using a modern contraception method between pregnancies, discontinue this contraception because they want to become pregnant and then become pregnant in the next three months. Women usually have a more chequered history with lactational amenorrhea, terminations, periods of attempting traditional methods of contraception, method switching, tightly spaced births, or long times to conception.
In contrast, some women do not use any form of contraception. The reason for non-use of contraception could be due to supply side (no access to contraception) or demand side (fear of side effects, lack of partner's support for use) issues. These women who do not use contraception may desire children, but they are not concerned with the timing or number of children. Thus, not all non-use translates to an unmet need for contraception. Unmet need is more precisely defined as "the proportion of fecund married women who wish to avoid further child bearing altogether or postpone their next child for at least two years, but who are using no method of contraception" [4] . While unmet need captures more the lack of contraceptive access, non-use of contraception also encompasses potential demand side influences. Thus, when non-use of contraception is discussed in this paper, it is not always due to unmet need and lack of access to contraception.
Here, I analysed the effect of contraceptive use (modern and traditional), contraceptive failure, and non-use of contraception on the health of subsequent children born. Child health is often proxied for by infant mortality; this outcome was studied here along with a range of nutritional outcomes. Anthropometric outcomes of stunting, wasting, and underweight were analysed as indicators of child health, as were diarrhoea and anaemia. The aim of this paper was to examine the effect of a woman's contraceptive history on subsequent child health. The effect of contraceptive use was isolated from birth spacing to identify the direct effects of contraception over and above the effect it had on spacing.
In this study, the definition of child health was not confined to infant mortality. Given the prevalence of poor child health outcomes in low-and middle-income countries, and only high infant mortality, studies that extend the monitoring of child health beyond infant mortality provide valuable information regarding health disparities and progress in achieving Millennium Development Goal 4, and its sub-goals relating to child health [42] .
The purpose of the current study was to assess the association between contraceptive use and child health outcomes of infant mortality, stunting, underweight, wasting, diarrhoea, and anaemia. The direct effect of contraceptive use on child health can be parsed out from tempo and quantum trends across socioeconomic status (SES) lines by controlling for birth spacing and socio-economic and demographic factors. Using secondary source data from 67 Demographic and Health Surveys conducted between 1990 and 2011, and utilizing data within the DHS from the reproductive calendar, 453,795 children aged between 0-59 months at the time of interview were in the study. The findings presented here on the additional beneficial effects of contraceptive use on child health could critically inform family planning policies. To my knowledge, such a systematic and comprehensive study of the effects of contraceptive use on subsequent child health has not been conducted.
METHODS

Data Source
Data from 67 Demographic and Health Surveys (DHS) conducted in 35 countries between 1990 and 2011 were analysed in this study [43] . The DHS are nationally representative household sample surveys that measure population, health, socio-economic, and anthropometric indicators, with an emphasis on maternal and child health [44] . The DHS are an important data source for studying population health across developing countries due to their extensive coverage, comparability, and data quality [45] [46] [47] . To ensure standardisation and comparability across diverse sites and time, Macro ICF employs intense interviewer training, standardised measurement tools and techniques, an identical core questionnaire, and instrument pretesting in conducting the DHS [48] . Each participating country reports detailed pretesting and quality assurance measures by survey [49] . In addition, the DHS is modular in structure, and for a selection of countries/surveys, the reproductive calendar and child height-weight modules were collected for analysis here. The DHS provides data with standardised variables across surveys [50] .
Sampling Plan
The DHS involves stratified cluster randomised samples of households [51] . The sampling frame was stratified by urban and rural status, and then additionally by country-specific geographic or administrative regions. Within each stratified area, random clusters of households were drawn from a list of all enumeration areas taken from a population census. In the second stage of sampling, all private households within the cluster were listed (institutions excluded) and an average of 25 houses within a cluster was selected by equal probability systematic sampling to be surveyed. Detailed sampling plans are available from survey final reports [49] .
Within each sampled household, a household questionnaire was administered and women eligible for a more detailed women's survey were identified. In most surveys, all women aged 15-49 years were interviewed. In a limited number of surveys, the target group was women aged 10-49 or 15-45 years, and never-married women. The child anthropometry module was conducted in a selection of the Standard DHS [52] .
The reproductive calendar was conducted in a subset of the DHS [53] . The reproductive calendar has two forms: one for low-contraceptive prevalence (Model B) countries and one for high-contraceptive prevalence (Model A) countries. In the Model B countries, pregnancies, terminations, and births were recorded whereas no information on intervening contraceptive use was collected. In Model A countries, in addition to pregnancies, terminations, and births, contraceptive use (modern and traditional) was recorded on a monthby-month basis for up to 80 months. Countries that changed from low-to high-contraceptive prevalence switch models (e.g., Ghana). In this study, information from Model A countries was used; thus, Model B countries (or surveys) that lacked the full monthly contraceptive history were excluded from the sample. The calendars were traced back 59-79 months from the time of the interview. Data were initially taken from the women's recode file (IR); the data were reshaped to make the child the observation. Thus, the panel structure is country, year, mother, and child. The DHS provides weights for calculating nationally representative statistics.
Study Population and Sample Size
In this study, each child health outcome had its own unique sample that reflected the characteristics of the outcome variable and complementary availability of the reproductive calendar data.
The infant mortality sample consisted of children born to women during the 12-79 months covered by the reproductive calendar. The lower bound of 12 months was applied to ensure that each child had equal exposure to one year of life and so that infant mortality (children who die within the first year of life) could be accurately calculated. The diarrhoea sample included all children aged 0-79 months and was self-reported by the mother if the child had diarrhoea in the two weeks prior to interview. Detailed child health biomarkers were only measured for children up to 60 months of age, which established the upper bound for the anthropometry and anaemia samples; the lower bound was 0 months. All children born within the reference period were included in the sample. Additionally, the start of the pregnancy for the index child was included within the reference period to ensure that contraceptive use behaviour could be observed prior to the pregnancy. Only surveys with Model A DHS were included in the initial sample. The initial infant mortality sample was 762,389 children across 38 countries from 76 surveys. The sample was reduced by 126,952, as children born within the past 12 months were excluded from the sample. Those children who died 1-5 years after birth (child mortality) were also excluded from the sample, further reducing the samples size by 8,984 observations. Some mothers did not agree to complete the reproductive calendar even though it was part of the survey; thus, a further 106,982 children were excluded from the sample. There is an extensive list of covariates, and in the multivariate analysis, 65,676 observations were lost due to these covariates. The final infant mortality sample for this study was 453,795 children across 35 countries and 67 surveys. Details of the samples for the child health outcomes are given (Table A1 appendix). Anthropometric samples are smaller because the child anthropometric module was not conducted in a number of surveys, and only children aged up to 36 or 59 months were measured. The samples consisted of the following numbers of children: stunting (360,785), wasting (360,137), underweight (369,881), diarrhoea (508,647), and anaemia (123,337).
Outcome Measures
In this study, I focused on six outcomes: infant mortality, stunting, underweight, wasting, diarrhoea, and anaemia. The birth history in the DHS Individual Recode records the survival status of a woman's (respondent's) child. A child's death and age of death was reported by the mother. Infants who passed away within the first year of life (<12 months) were counted as an infant mortality.
Anthropometric failure was captured in three outcomes: stunting, underweight, and wasting. First, a z-score determined by the child's height minus the median height for that child's age and sex in a reference population was calculated. The resulting value was divided by the standard deviation of the same age and sex in the World Health Organization (WHO) reference population of healthy children in developing countries [54] . Stunting was defined as a height z-score of <-2. Similarly, underweight was defined as a z-score of <-2 for weight relative to children of the same sex and age in the reference population. Wasting was defined as a z-score of <-2 for weight-to-height relative to children of the same sex and age in the reference population. Biologically impossible values were defined by the WHO for height (stunting) as z-scores of <-6 or >6; for weight (underweight) as <-6 or >5; and for weight for height (wasting) as <-5 or >5, and those out of the feasible range were excluded from the sample.
The outcome of child diarrhoea was based on the mother's recall of whether their child had diarrhoea within the two weeks prior to interview. Anaemia was measured by a finger stick blood test from the child at the time of interview. The first two drops of blood were discarded, and the third drop was taken as a sample. The blood drop was analysed using the HemoCue system. Adjustments for altitude were taken into account, and children with a haemoglobin concentration less than 10 g/dL were considered as having moderate anaemia.
Exposure and Covariates
The explanatory variable of interest in this study was the woman's contraceptive history prior to the pregnancy and birth of the index child. Contraceptive use was monitored between the start of the pregnancy that resulted in the index birth and the preceding birth. For example, if two children were born within the reference period and both pregnancies also started within the reference period, the contraceptive behaviour of the mother between the two pregnancies could be observed. The history of contraceptive use prior to the pregnancy of the elder of the two children was observed from the start of the pregnancy of that child back to the start of the reproductive calendar. Contraceptive use before pregnancies categorised into eight groups: no contraceptive failure and used modern contraception . Failure was defined as using contraception for one month and then being pregnant with the index child the following month. These categories are mutually exclusive. Thus, the contraceptive history of the mother prior to the pregnancy of the index child was taken as the last reproductive event prior to the start of that pregnancy. Thus, women who had a termination prior to the pregnancy of the index child and then after that termination used no form of contraception (traditional or modern) before the pregnancy of the index child fell into the category of No failure/Termination. A woman who had a birth, had lactational amenorrhea, then used the rhythm method, and then went on a hormonal contraceptive pill before stopping all contraception prior to the start of the pregnancy of the index child was coded as No failure/Modern use.
In addition to the explanatory variables of interest, a number of other covariates were also controlled for that includes child, maternal, and paternal characteristics, as well as household and social factors. The child characteristics were the child's sex, singleton or multiple births, the age of the child in months, and interpregnancy birth interval. The covariate for the age of the child was not included in the infant mortality model, but was included in all other models. Child age in months was categorised into five groups: 12-23, 24-35, 36-47, 48-59, and 60-79 (0-11 month olds were included in all samples other than infant mortality). The birth interval was the number of months between the index birth and the preceding birth. First births comprised their own category, and then birth intervals were grouped into 1-11, 12-24, and >24 months.
The maternal factors included in this study were the mother's age and education. The age of the mother at first birth was a variable reported in the DHS recode manual [50] and was calculated as from the century month code (CMC) of the date of the first birth and the CMC of the date of birth of the mother. Age was categorised into five-year intervals: ages 12-14, 15-19, 20-24, 25-29, 30-34, 35-39, 40-44 , and 45-49 years. Maternal education was classified into three categories: no education or less than completed primary, completed primary, and completed secondary or higher. Paternal covariates were captured by variables that indicated whether the woman had a partner, and if so, the partner's education level. The partner's education followed the same classifications as coded for the mother's education described above.
Household and social factors included the wealth quintile of the household and whether the household was in a rural or urban location. The wealth quintile is a within-country measure of the wealth of the household relative to other households in that survey based on its ownership of household assets. This measure of wealth, generated by Filmer and Pritchett [55] , is a linear index of asset ownership indicators using principal component analysis to derive weights. This measure has been standardised by Measure DHS across most of the DHS and is widely used as a measure of relative wealth within a country. Given that country fixed effects are controlled for in the regression analyses, this wealth index is an indicator of how each household's wealth deviates from its own country's mean wealth. Indicators for piped water to the house were also included as covariates, as well as the presence of a flush toilet in the household. In addition to these household measures, a cluster level health measure was included: the percentage of living children aged 12-60 months who had received a measles vaccination in the cluster. There were no vaccination data for children who died, and the cluster level measles vaccination percentage enables neighbourhood health system inputs to be controlled for. The measles vaccine was administered between 9-12 months of age and was likely to have only a limited direct effect on infant mortality. The vaccine coverage may be thought of as a proxy for health care provision to assist in parsing out the direct effects of contraceptive use from the general health effects of health care provisions that may be correlated with contraceptive access.
Statistical Analysis
To measure the relative risk of a given outcome, a modified Poisson regression was applied following Zou's [56] methodology for the high prevalence child health outcomes, which are all but infant mortality, for which I used a logit regression. The unadjusted model was estimated controlling for country fixed effects and year of birth dummies to account for the uneven repeated cross section. The adjusted model was then estimated and included the covariates. While summary statistics were weighted to take into account the multistage sampling design, the regressions were not weighted [57] .
RESULTS
Summary Statistics
Average No failure/Non-use of the 67 DHS was 20.41. This ranged from an average of 5.06 in Moldova in 2005, to an average of 37.17 in Guatemala in 1995 ( Table 1) . Ethiopia in 2005 (36.36) and Colombia in 2000 (5.11) were near the extremes. Across the 67 surveys, infant mortality was highest in Sierra Leone in 2008, at 10.62%. In 28 of the 58 surveys, 30% or more of the children were stunted, and 43 of the 58 survey country/years had stunting rates of 20% or higher. Bangladesh in 1996 had the highest average stunting and underweight rates, 57.75% and 52.88%, respectively. An underweight prevalence of 25% or more was present in 9 of the 57 surveys. Wasting (weight-for-height) was not as prevalent as stunting; 12 of the 57 surveys recorded an average wasting prevalence of 10% or more. An average of 30.08% children in Turkey in 1998 suffered diarrhoea within the two weeks prior to the DHS interview, but across the 67 surveys, the average was 13.72%. Anaemia was recorded in 27 of the surveys that also had reproductive calendar. In those 27 surveys, average anaemia rates ranged from 6.21% children in Albania in 2008 to 55.85% in Ghana in 2008. The average was 32.63% across the 27 surveys ( Table 1 ).
In the infant mortality model (n=453,795 children), contraceptive use prior to the pregnancy and birth of the index child was observed. I was unable to observe the full history prior to 46.46% of pregnancy/births, as the length of the calendar was truncated at 79 months and the previous birth occurred prior to the start date of the calendar. In 20.75% of the cases prior to pregnancy/birth of the index child, women did not use any form of contraception (traditional nor modern). Failure of modern and traditional contraception occurred in 6.16% and 5.81% of cases, respectively, while 14.22% of cases used modern contraception successfully. Terminations, lactational amenorrhea, and successful use of traditional methods of contraception were rare ( Table 2) . First births comprised 28.55% of the sample, and most women practiced spacing, with 54.81% of children born >24 months after their previous sibling. Family sizes varied; 27.24% of children had five or more siblings at the time of the interview. Children of multiple births were rare (2.39%), most women (97.66%) had partners, 62.49% of children were born in rural areas, 44.22% had piped water to the house whereas the remainder left the house to collect water, and 37.13% of children had a flush toilet at the house. Distributions of covariates were similar across the different outcome models ( Table 2) .
Two dominant groups emerged from the data collected: those cases where there was successful use of modern contraception between births (No fail/Modern use), and those cases where there was no use of contraception between births (No fail/Non-use) ( Table 2 ). The characteristics of women who fell into these two groups are presented in Table 3 . In cases where there was no use of contraception, birth intervals were shorter on average (20.31% with a 12-17-month interval and 50.76% with a >24-month interval) than in cases where there was successful use of modern contraception (1.8% with a 12-17-month interval and 78.13% with a >24-month interval) and failure of modern contraception (5.97% with a 12-17-month interval and 69.21% with a >24-month interval) ( Table  3) . Of the non-use cases, 40.93% had >5 siblings to the index child, compared to 20.81% of the successful modern contraceptive use cases and 25% of the modern failure cases. Non-use of contraception was associated with low education; 64.91% of cases were women with no education or incomplete primary. Successful modern use (36.05%) and modern failure (33.35%) had a lower prevalence in women with no education or incomplete primary. Of the cases that present as non-use, 74.59% were rural households, and this percentage was lower for successful modern use (51.41%) and modern failure (44.71%) cases (Table 3) . Women who did not use any contraception between births stood apart from women who did use modern contraception (even if they experienced contraceptive failure); women who did not use contraception were socially disadvantaged, on average, compared to women who did use contraception. Thus, contraception use is what made women similar, whereas contraceptive failure can occur at random and thus affect any contraceptive user and not a particular sub-group of user.
Unadjusted and Adjusted Models
The absolute probability of poor child health outcomes by contraceptive history is presented in Table 4 . The cases of non-use resulted in the highest prevalence of poor child health outcomes, except for the case of diarrhoea where a prior termination led to the next child having an absolute probability of diarrhoea of 17.03% (95% CI [confidence interval]: 16.37, 17.70). If there was no use of contraception between the birth of the index child and the prior child, then the index child had a 41.97% (95% CI: 41.48, 42.46) probability of stunting. However, if modern contraception was used successfully in the interim, the index child had a lower probability of stunting (24.71%, 95% CI: 24.24, 25.18), and if modern contraception was used but failed, leading to the birth of the index child, then that child had a 22.77% (95% CI: 22.11, 23.45) probability of being stunted. Modern failure led to a child that had a statistically similar probability of infant mortality and anaemia to successful use of modern contraception prior to the index child's birth. In the cases of diarrhoea and anthropometric failure outcomes, births that resulted from contraceptive failure yielded better child health outcomes than if there was successful use of contraception in the interim between the index birth and previous child ( Table 4) . The unexpected nature or the potential unwantedness of these children did not appear to affect their health outcomes.
The unadjusted relative risk of the six child health outcomes by contraceptive history are reported in Table 5 . Non-use of contraception prior to the birth of the index child had the highest relative risk of poor child health outcomes on all but diarrhoea (where it was second to a prior termination). The case of successful modern contraceptive use was the baseline case, with the default risk of 1.00; other contraceptive history As shown in Table 3 , women who had a case of non-use prior to the birth of the index child were socially disadvantaged compared to women who used modern contraception, even when compared to contraceptive users who experienced a failure of that contraception. Thus, in the unadjusted model, it may be that the correlates of non-contraceptive use, which represent social disadvantage that drive the poor child health outcomes, and non-contraceptive use had no direct effect on poor child health outcomes. Moreover, as contraceptive use is correlated with wider birth intervals, it may be that contraceptive use proxies for the birth interval and that contraceptive use had no direct effect on child health. In Table 6 , demographic and social covariates were included in the multivariate model to identify the direct effects of contraceptive history on child health outcomes independent of social and demographic characteristics. In short, inclusion of demographic and social characteristics in the multivariate model did not alter the main conclusion from the unadjusted model that non-use of contraception prior to the birth of the index child led to the highest risk of poor child health outcomes across five of the six outcomes included in this study ( Table 6) . Consider the stunting sample, column 2 of Table 6 : non-use of contraception prior to the pregnancy/birth of the index child yielded the highest relative risk (RR) of a stunted child (RR 1.120, 95% CI: 1.101, 1.140), and modern failure was not significantly different from successful use of modern contraception (RR 0.990, 95% CI: 0.965, 1.106). Moreover, successful traditional contraceptive use prior to the birth of the index child had no significantly different effect on child health than successful modern contraceptive use (RR 1.029, 95% CI: 0.998, 1.061). A child that was born following the failure of a traditional contraceptive method, however, was more likely to be stunted (RR 1.064, 95% CI: 1.039, 1.090) compared to the reference group. Regarding other child health outcomes, non-use ranged from a relative risk of anaemia of 1.045 RR (95% CI: 1.014, 1.077), 1.114 RR (95% CI: 1.068, 1.163) for wasting, 1.161 RR (95% CI: 1.130, 1.194) for underweight, and 1.244 RR (95% CI: 1.179, 1.312) for infant mortality. Modern failure was not significantly different from modern use in any of the child health outcomes. A prior termination led to poor child health outcomes in terms of the index child's stunting, underweight, and diarrhoea. Traditional contraceptive failure only resulted in a higher risk of stunting and underweight, but not of the other child health outcomes.
In the stunting sample, the risk of stunting declined with the mother's age through to age 40-44 years.
Short birth intervals (12-17 months) increased the risk of stunting compared to intervals of >24 months (RR 1.125, 95% CI: 1.104, 1.147). Female children were less likely to be stunted (RR 0.911, 95% CI: 0.903, 0.919) than male children. There was a positive education gradient for child health; mothers who had no education or incomplete primary at the time of the interview Had a relative risk of having a stunted child of 1.394 (95% CI: 1.361, 1.428) compared to women with secondary education. The father's education also had a positive effect on child health, although to a lesser extent (0.906 RR of completed secondary compared to no education, 95% CI: 0.889, 0.923). The risk of stunting declined with wealth, and children in rural areas were more likely to be stunted (1.083 RR, 95% CI: 1.065, 1.101). A higher cluster level average vaccination rate also reduced the risk of stunting.
In Figure 1 , the adjusted relative risks of the key outcome of No failure/Non-use were compared to other key variables of education (age of the mother and birth interval). Each of these outcomes had a significant effect on child health. However, the independent effect of non-contraceptive use is not dwarfed by any of the other adjusted covariates. Thus, contraceptive use is just as important to child health outcomes as the wellknown predictors of child health such as mother's age, education and birth interval.
DISCUSSION
Principal Findings
In this paper, I demonstrated that successful contraceptive use (modern use in particular, but also traditional use) had a positive effect on child health outcomes over and above the birth spacing effect compared to non-use of contraception in the intervening period between pregnancies. Contraceptive use increased birth spacing, and greater birth spacing has a positive effect on child health, but contraceptive use also had a direct positive effect on child health outcomes. This may be due to the greater access or knowledge of maternal and child health issues available to women who use contraception. Moreover, failure of modern contraception had no adverse effect on the health of the resultant child compared to successful use of modern contraception in the intervening period.
The results presented here indicate that contraceptive use, even if used unsuccessfully, provided positive health outcomes for subsequent children. Non-use of contraception in the intervening period led to poor child health outcomes, and this was not exclusively due to shorter inter-pregnancy periods. In contrast, the negative effect of non-use of contraception on child health was evident across all outcomes analysed in this study: infant mortality, stunting, wasting, underweight, diarrhoea, and anaemia.
Non-use of contraception was associated with low SES. Cross-tabulation in Table 3 demonstrated that of women who were non-users of contraception, more were in the poorest wealth quintile (24.29%) compared to those women who were successful users of modern contraception (19.01%). The same disparity existed for education level (non-users had lower education levels), rural living, and the presence of water and sanitation facilities at the house. Partners of non-users also had lower education levels. Contraceptive failure was not marked by women who were disadvantaged.
Women who used contraception, whether the contraception failed or not, were more advantaged than those women who did not use any contraception. Women who did not use contraception also had shorter birth intervals between births compared to users of modern (and traditional) contraception. These differences were large. Of the women who did not use contraception, 24.48% of them had children spaced 18-23 months apart; of those who used modern contraception successfully, 5.54% had children spaced 18-23 months apart; and for those who used modern contraception that failed, 10.54% had children spaced 18-23 months apart. Thus, non-contraceptive use was clearly associated with shorter birth intervals, but the multivariate analysis highlights that contraceptive use had a positive effect on child health in addition to the effect it had on widening birth intervals.
Comparisons to other Studies
Consistent with other studies, I found beneficial effects of contraceptive use on child health outcomes [4, 7] . Cleland et al. [7] focus on the effect of extended birth interval on child health outcomes; however, these authors did not analyse the direct effect of contraception on child health outcomes. In this paper, it was shown that contraceptive use was associated with longer interpregnancy intervals, thus supporting Cleland et al.'s [7] analysis. Cleland et al. [7] also analysed the effect of birth interval on infant mortality, child mortality, and stunting. They found that the risk of these poor child health outcomes decreases as the birth interval increases (although for infant mortality, intervals longer than four years result in a slightly increased risk). In the current study, the analysis was taken to a deeper level, examining the contraceptive practices of individual women and the effect of those practices on subsequent children. The ranges of health outcomes examined in this paper were also more comprehensive than any other study conducted to date to my knowledge.
Limitations of the Study
Although this study provided important insights into the benefits of contraceptive use, there are certain limitations that should be considered when interpreting the results. The primary variable of interest, contraceptive history, is subject to measurement error as data collection of this variable relies on recall by the respondent on a month-by-month basis for up to 80 months prior to the interview. As the contraceptive history data are drawn from a different variable than the child health outcomes and birth (and death) history, there is a possibility that the three histories do not agree. This was easily confirmed with the variable of the age of the child that can be calculated using all three histories. For the sample used in this study, I found near perfect agreement across the three histories.
A further limitation of the model is that the socioeconomic measures of male and female education, together with the wealth index, may not fully capture the SES of the woman and her child. While I included information regarding location of residence, piped water to the house, and flush toilets, these all served as proxies for actual SES. Any unobserved wealth captured in the residual will confound the current results. Factors such as actual household income and education quality are such variables that we are unable to control for in the regression and may significantly influence child health outcomes and shape our understanding of the role of SES factors.
In general, observational studies are subject to the limitation of omitted variables. In this case, there may have been variables that were spuriously correlated with contraceptive use, but for which I did not control. This would mean that the significance attributed to contraceptive use behavior as a significant spurious correlate of child health outcomes may in fact be a proxy for other omitted factors. Fixed effects on year of birth are included in both the unadjusted and adjusted regressions to control for common factors in a given year, and secular changes over time. Country fixed effects were also included in the unadjusted and adjusted regressions to control for factors that may have been common to women within the same country and were unchanging over time. The covariates controlled for deviations from the country average and the global time trends in the variables included in the adjusted regressions. However, there may be some factors that were correlated to the explanatory variable of interest that were omitted from the regression, in which case the regression coefficients suffered from omitted variable bias.
One of the key outcomes of interest in this study was infant mortality. Infant mortality was aggregated across all causes of death. However, it could be reasonably expected that the contraceptive history of the mother affected infant mortality outcomes that were attributed to a specific cause of death. Using a range of child health outcomes in this study, I illustrated how the age of the mother was differentially (or similarly) related to various outcomes. However, an investigation of the vulnerability of death by pneumonia, diarrhoea, malaria, or AIDS, for example, by the age of the mother is beyond the scope of this study as cause of death for children is not recorded in most DHS.
CONCLUSIONS AND IMPLICATIONS
The results of this study provide an additional force in the setting of the family planning agenda. In this study, it was clear that contraceptive use (particularly the use of modern contraception) had a positive effect on child health. This is in part due to an indirect effect of long inter-pregnancy intervals, but contraception also has an additional direct effect on child health over and above the positive influence of spacing. The use of family planning has an equal, and independent, effect on child health as female education and the age of the mother at birth. While family planning is known to have indirect effects on health through assisting with birth spacing, empowering women to stay in school, and delay of first birth, the findings in this paper highlight the large direct benefits contraceptive use has on child health.
The findings in this paper bring family planning to the centre stage as an effective mechanism to help achieve the Millennium Development Goals, namely MGD4 of Child Health.
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